It was especially surprising that CDK8 and CDK19 expression showed correlations (albeit weak) with a longer rather than shorter survival in AML, the only disease where a large subset of cell lines was found to be highly susceptible in vitro to CDK8/19 inhibitors [11,12]. Here, CDK8 is linked to acute myeloid leukemia.